openPR Logo
Press release

Biochips Market Share, Size, Drivers, Barriers, Landscape | Key Companies- Roche Ltd, Fluidigm Corporation, Illumina, HORIBA, PerkinElmer, QIAGEN N.V.

04-12-2022 05:49 AM CET | Health & Medicine

Press release from: DelveInsight Business Research

Biochips Market

Biochips Market

The biochip is used to simultaneously analyze a panel of related tests in a single sample, producing a patient profile. The patient profile can be used in disease screening, diagnosis, monitoring disease progression or monitoring treatment.

DelveInsight's 'Biochips Market Insight, Competitive Landscape and Market Forecast, 2026' report delivers an in-depth understanding of Biochips and the historical and forecasted Biochips market trends, globally, which comprises of North America, Europe, APAC, and RoW.

To Know more about Biochips Market report: https://www.delveinsight.com/report-store/biochips-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Some of Biochips Companies are:
• bioMrieux S.A.
• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche Ltd.
• Fluidigm Corporation
• Illumina, Inc.
• HORIBA, Ltd.
• PerkinElmer, Inc.
• QIAGEN N.V.
• Randox Laboratories Ltd.
• Thermo Fisher Scientific Inc.
• And Many Others

For further information on the Biochips companies and their pipeline, reach out @ https://www.delveinsight.com/report-store/biochips-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Some Facts of Biochips Market Report are:

• As per National Cancer Institute, by 2040, it is projected that the number of new cancer cases will upsurge by 29.5 million and the number of cancer-related deaths to 16.4 million per year.
• The increasing prevalence of chronic diseases is poised to help the market grow. As per world health organization (WHO), an estimated 17.9 million people died from Cardiovascular diseases (CVDs) in 2019, which represented 32% of all global deaths.
• In 2019, as per American Heart Association, 2019 around 121.5 million U.S. adults have some form of cardiovascular disease.
• In Europe, the market is growing owing to factors such as presence of prominent players that have adopted substantial strategies such as product launch and acquisitions etc. and rising prevalence of cancer diseases as biochips transform the way in which medical field diagnoses cancer.
• In 2020, as per American cancer society, Europe accounts for 22.8% of the total cancer cases and 19.6% of the cancer deaths. Asia Pacific is supplemented by factors such as huge number of the patient pool which requires early detection of diseases and presence of major players in the market is propelling the growth.

Request for Sample Report: https://www.delveinsight.com/sample-request/biochips-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Biochips Market Drivers:
Increase in prevalence of cancer, immunological disorders, and viral infections majorly drives the growth of the global biochips market. Other factors that boost the market growth include rise in geriatric population, increase in number of biochip applications, and high adoption of personalized medications. However, factors such as high cost of biochip and lack of knowledge about it majorly in emerging nations hamper the market growth.

For further information on the Biochips companies and their pipeline, reach out @ https://www.delveinsight.com/report-store/biochips-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Scope of the Biochips Market Report

• The report covers the descriptive overview of Biochips, explaining its applications, advantages, and limitations, etc.
• Additionally, detailed profiles of the Key Companies operating in the market is provided, along with the market share of the Key 3-5 players.
• A detailed review of Biochips market; historical and forecasted market size is included in the report, covering global outreach.
• The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Biochips market.

Find a sample copy of the Biochips Market report: https://www.delveinsight.com/report-store/biochips-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Table of Contents:
1. Biochips Market Report Introduction
2. Biochips Market Executive summary
3. Regulatory and Patent Analysis
4. Biochips Market Key factors analysis
5. Biochips Porter's Five Forces Analysis
6. COVID-19 Impact Analysis on Biochips Market
7. Biochips Market layout
8. Biochips Global Company Share Analysis - Key 3-5 Companies
9. Biochips Company and Product Profiles
10. Project Approach
11. KOL Views
12. DelveInsight Capabilities
13. Disclaimer
14. About DelveInsight

Request for TOC @ https://www.delveinsight.com/report-store/biochips-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

DelveInsight's Competitive Intelligence Service includes a multidimensional coverage, helping to keep track of competitors and gain traction in the dynamic market by overcoming the challenges and expediting business growth through a strategic and tactical approach.

About Delveinsight:
DelveInsight Business Research is a leading Market Research, and Business Consultant focused purely on Healthcare. It helps pharma companies by providing them with end-to-end services to solve their business problems.
Get hold of all the Pharma and healthcare market research reports on our market research subscription-based platform PharmDelve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
Phone: +19193216187
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

DelveInsight is a leading Life Science market research and business consulting company recognised for its off-the-shelf syndicated market research reports as well as customised solutions to firms in the healthcare sector.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biochips Market Share, Size, Drivers, Barriers, Landscape | Key Companies- Roche Ltd, Fluidigm Corporation, Illumina, HORIBA, PerkinElmer, QIAGEN N.V. here

News-ID: 2600479 • Views:

More Releases from DelveInsight Business Research

Pharma Asset Management Success Story: Strategic In-Licensing in the Atrial Fibrillation Space by DelveInsight
Pharma Asset Management Success Story: Strategic In-Licensing in the Atrial Fibr …
DelveInsight, a leading business consulting and market research firm, is pleased to announce the successful completion of an Asset Prioritization project that enabled a mid-sized pharmaceutical client to identify, evaluate, and secure a high-value therapeutic asset for in-licensing in the Atrial Fibrillation (AF) space. The case study highlights how evidence-based insights, structured methodologies, and multi-layered evaluations supported the client in achieving its long-term strategic growth goals. Objective of the Case Study The
Myopia Clinical Trials Outlook 2025: Competitive Landscape, Regulatory Milestones, Therapies in Development, Mechanisms of Action, and Routes of Administration - By DelveInsight
Myopia Clinical Trials Outlook 2025: Competitive Landscape, Regulatory Milestone …
(Albany, USA) - DelveInsight's newly released report, "Myopia Pipeline Insight 2025," delivers an in-depth assessment of the clinical trial landscape, regulatory progress, and therapeutic development trends shaping the Myopia therapeutics market. The analysis highlights ongoing clinical advancements, pipeline opportunities, and the potential impact of emerging therapies on patient care and market dynamics. According to DelveInsight's evaluation, the Myopia pipeline remains highly active, with 8+ pharmaceutical and biotechnology companies investigating more than
Global Biopsy Devices Market to Reach USD 10.81 Billion by 2032, Driven by Rising Cancer Burden and Technological Advancements, states DelveInsight
Global Biopsy Devices Market to Reach USD 10.81 Billion by 2032, Driven by Risin …
The global biopsy devices market is poised for significant growth, with market size projected to increase from USD 5,813.16 million in 2024 to USD 10,812.77 million by 2032, expanding at a CAGR of 8.09% during 2025-2032. The robust expansion is being driven by the growing incidence of cancers, rising demand for minimally invasive diagnostic procedures, and rapid advancements in biopsy technologies. Biopsy devices play a crucial role in disease diagnosis by
Global General Surgery Devices Market to Reach USD 35.4 Billion by 2032, Driven by Rising Surgical Procedures, Technological Advancements, and Growing Adoption of Minimally Invasive Techniques, States DelveInsight
Global General Surgery Devices Market to Reach USD 35.4 Billion by 2032, Driven …
According to the latest market analysis, the global general surgery devices market is set for robust growth, increasing from USD 21,786.29 million in 2024 to USD 35,399.63 million by 2032, expanding at a CAGR of 6.34% during 2025-2032. This growth reflects a surge in surgical procedures, continuous technological advancements, and rising demand for minimally invasive and robotic-assisted surgical techniques across healthcare systems worldwide. DelveInsight's General Surgery Devices Market Report 2032 provides

All 5 Releases


More Releases for Biochips

Impact of Personalized Medicine On Biochips Market: Pivotal Factor Influencing B …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Biochips Market Size Growth Forecast: What to Expect by 2025? In recent years, the size of the biochips market has seen significant expansion. It is forecasted to rise from $12.62 billion in 2024 to $14.72 billion in 2025, with a compound annual growth rate (CAGR) of 16.6%. The surge
Impact of Personalized Medicine On Biochips Market: A Key Driver Powering Biochi …
The Biochips Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Current Biochips Market Size and Its Estimated Growth Rate? The biochips market has seen rapid growth in recent years. It is expected to grow from $12.62 billion in 2024 to $14.72 billion in
Primary Catalyst Driving Biochips Market Evolution in 2025: Impact of Personaliz …
Which drivers are expected to have the greatest impact on the over the biochips market's growth? The biochips market is expected to thrive due to the rising acceptance of personalized medicines. Tailoring medical treatment according to an individual's specific characteristics like genetics or lifestyle defines personalized medicine. It's been witnessing an increase in demand on account of its ability to offer more efficient treatments, advancements in genomics, the rise in disease
Biochips Market: Crucial Role of Biochips in Drug Discovery and Development
The vendor landscape of the global biochips market is extremely fragmented, speckled with a number of small, medium, and large enterprises. Considering that it is not a monopolistic scenario, the entry of new players is not restricted, giving vendors immense scope. In view of this, Transparency Market Research finds that despite being the leading players in the biochips market, Affymetrix Inc., Agilent Technologies Inc., and Illumina Inc. together accounted for
Biochips Market Report
According to the new market research report, “Biochips Market, by Types (Protein Chips, DNA Chips, Lab-on-a-chip), Fabrication Technologies (Microarrays, Microfluidics), Applications (Drug Discoveries, Gene Expression, Genomics, In-vitro Diagnostics, Proteomics) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022”, published by Scalar Market Research, the global biochips market is expected to grow at a healthy rate during the forecast period. The global biochips market report offers in-depth analysis of the
Biochips Market Rises due to Rising Investments in Development of Biochips Techn …
Biochips are a collection of microarrays or micro-test sites fixed on a solid substrate to perform multiple tests at the same time for achieving enhanced speed and throughput. They are small, wafer-like components that are made from substrates such as soda glass, fused quartz, silicon, and plastic. Biochips are effectively a miniature laboratory that functions to perform several biochemical reactions simultaneously. INFORMATION OF BIOCHIPS MARKET WORLDWIDE: http://www.transparencymarketresearch.com/biochips-market.html The positive growth rate in the